Franklin Genomic Advancements ETF (HELX)

Market Cap: $9.54M

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

5.62% less ownership

Funds ownership: 31.67% [Q1] → 26.05% (-5.62%) [Q2]

20% less capital invested

Capital invested by funds: $3.11M [Q1] → $2.48M (-$636K) [Q2]

27% less funds holding

Funds holding: 11 [Q1] → 8 (-3) [Q2]

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4